Target intelligence / Profile preview

Intestinal mucosa and gut microbiota ecosystem

Molecular classification
Other
01

Overview

The intestinal mucosa and gut microbiota ecosystem is a complex, symbiotic functional unit comprising the host's intestinal epithelial cells, the protective mucus layer, and a diverse community of microorganisms including bacteria, fungi, and viruses. This ecosystem is fundamental to human health, performing essential roles in nutrient metabolism, vitamin synthesis, and the development and regulation of the mucosal immune system (NIH, 2023). It acts as a dynamic barrier that prevents the translocation of pathogens and toxins while maintaining tolerance to commensal microbes and dietary antigens (Nature Reviews Gastroenterology & Hepatology, 2020). Disruptions to this ecosystem, often termed dysbiosis, are implicated in a wide range of pathologies, including inflammatory bowel disease (IBD), metabolic syndrome, and susceptibility to infections like Clostridioides difficile (PubMed, 2021). Therapeutic interventions targeting this system include probiotics, prebiotics, and fecal microbiota transplantation, which aim to restore microbial balance and reinforce the intestinal barrier. Understanding the intricate cross-talk between the microbiota and the host mucosa is a primary focus for developing novel treatments for chronic inflammatory and autoimmune conditions.

Other names
Gut microbiomeIntestinal barrierGut-microbiota-mucosa axisIntestinal microfloraGastrointestinal ecosystem
02

Mechanism of action

Modulation of microbial composition, restoration of epithelial barrier integrity, competitive inhibition of pathogenic bacteria, and regulation of mucosal immune homeostasis through the production of metabolites like short-chain fatty acids.

03

Biological functions

Immune responseMetabolismPathogen defenseBarrier maintenanceSignal transduction
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeObesityClostridioides difficile infectionColorectal cancerMetabolic syndrome
05

Safety considerations

Risk of systemic infectionTransfer of antibiotic resistance genesPotential for inducing dysbiosisLong-term impact on host metabolism
06

Interacting drugs

Rifaximin

8 more in the full profile.

07

Biomarkers

Fecal calprotectinZonulinMicrobial alpha diversityShort-chain fatty acidsSecretory IgA

Beyond the preview

Go deeper on Intestinal mucosa and gut microbiota ecosystem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal mucosa and gut microbiota ecosystem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call